Clinical Trials Directory

Trials / Completed

CompletedNCT01951300

68Ga-Citrate PET of Healthy Volunteers

68Ga-Citrate Positron Emission Tomography (PET) of Healthy Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Turku University Hospital · Other Government
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

This study investigates whole-body distribution kinetics of intravenously administered Gallium-69 (68Ga) citrate by positron emission tomography (PET)/computed tomography (CT). Thereafter, radiation dosimetry of 68Ga-citrate PET/CT will be determined.

Detailed description

Six healthy male volunteers are recruited in this study. Gallium-68 citrate radiopharmaceutical is intravenously injected as a bolus and whole-body distribution kinetics are studied by dynamic whole-body positron emission tomography/computed tomography. During imaging, serial venous blood samples are drawn, plasma is separated and radioactivity is measured by gamma counter. Immediately after imaging session, urine is voided and radioactivity is measured by gamma counting. As a final point, radiation dosimetry due to single Gallium-68 citrate injection is determined.

Conditions

Interventions

TypeNameDescription
OTHERGallium-68 citrateSingle intravenous bolus injection of 200 MBq of Gallium-68 citrate radiopharmaceutical

Timeline

Start date
2013-09-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2013-09-26
Last updated
2015-11-04

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01951300. Inclusion in this directory is not an endorsement.